# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001453687-25-000098
Filing Date
2025-08-07
Accepted
2025-08-07 07:05:19
Documents
14
Period of Report
2025-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | rnac-20250807.htm iXBRL | 8-K | 30868
2 | EX-99.1 | exhibit991_earningsrelease.htm | EX-99.1 | 127926
6 |  | cartesian_logoxcolorxcmyka.jpg | GRAPHIC | 1268513
| Complete submission text file | 0001453687-25-000098.txt |  | 1963934

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | rnac-20250807.xsd | EX-101.SCH | 1862
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | rnac-20250807_lab.xml | EX-101.LAB | 21885
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | rnac-20250807_pre.xml | EX-101.PRE | 12572
16 | EXTRACTED XBRL INSTANCE DOCUMENT | rnac-20250807_htm.xml | XML | 2722

Mailing Address 7495 NEW HORIZON WAY FREDERICK MD 21703
Business Address 7495 NEW HORIZON WAY FREDERICK MD 21703 301-348-8698
Cartesian Therapeutics, Inc. (Filer) CIK: 0001453687 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37798 | Film No.: 251191533
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)